In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Jailing the MCA to Treat Uncoilable and Surgically Inaccessible ICA Termination-region Aneurysms

    Final Number:
    131

    Authors:
    Matthew T Bender MD; Bowen Jiang MD; Jessica K. Campos MD; Erick M Westbroek MD; Risheng Xu AB AM MD PhD; Chau D. Vo BA; Justin M. Caplan MD; Judy Huang MD; Rafael Jesus Tamargo MD; Li-Mei Lin BA; Geoffrey P. Colby MD, PhD; Alexander L. Coon MD

    Study Design:
    Other

    Subject Category:
    Aneurysm/Subarachnoid Hemorrhage

    Meeting: AANS/CNS Cerebrovascular Section 2018 Annual Meeting

    Introduction: Flow diversion of ICA termination (ICAT) aneurysms is an option when surgical or other endovascular techniques are inadequate. Jailing the ACA with a flow diverter is effective when the Acom is patent. Jailing the MCA, a truly terminal circulation, is sometimes necessary and has not been reported.

    Methods: A prospective, IRB-approved database was analyzed for patients with PED placement from the ACA to the ICA during cerebral aneurysm treatment.

    Results: Nine cases were identified, including 5 proximal A1, 3 Pcom, and 1 ICAT aneurysm locations. Average aneurysm size was 8.3mm (range 3-17), with 67% saccular and 78% right-sided. Primary indication for treatment was significant dome irregularity (44%), recurrence or enlargement (33%), underlying collagen vascular disorder (11%), and traumatic pseudoaneurysm (11%). Preservation of the ipsilateral ACA (with PED placed in A1) was performed when the Acom (67%) or contralateral A1 (33%) were absent on angiography. Adjunctive coiling was done in 4 cases (44%). One major stroke occurred. This patient had an irregular 8mm proximal left A1 aneurysm treated with PED and coiling. Post-treatment angiography showed slight left MCA delay, however, hypotension during management of a retroperitoneal hematoma requiring surgical repair led to left MCA stroke ultimately resulting in death. Follow-up DSA in all other patients (average interval 15mos) showed complete aneurysm obliteration (100%). The jailed MCA showed minimal or mild delay (primarily anterograde flow) in 75% of cases and significant delay (reliance primarily on ACA and ECA collaterals) in 25%. One patient experienced mild weakness from MCA watershed territory ischemia during vasovagal hypotension after treatment and is currently mRS=2 at 18 months follow-up.

    Conclusions: Rare circumstances necessitate jailing the MCA with a flow diverting stent. With strict attention to perfusion pressures during a period of collateral recruitment, excellent occlusion outcomes can be achieved while minimizing ischemic risks.

    Patient Care: This study will improve current knowledge of the clinical ramifications of jailing the MCA with a flow diverting device for the treatment of ICA aneurysms.

    Learning Objectives: By the conclusion of this session, participants should be able to: 1) Describe the circumstances warranting consideration of jailing the MCA with a flow diverting stent; 2) Discuss, in small groups, the occlusion outcomes and risks associated with jailing the MCA as presented in this case series.

    References: --

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy